Shanghai Henlius Biotech

This study is testing whether adding a new antibody called HLX07 to standard immunotherapy and chemotherapy works better for people with advanced squamous non-small cell lung cancer. Researchers will compare different combinations of treatments in 720 participants who haven't had…

This study is testing an experimental drug called HLX43 in people with advanced pancreatic cancer that has continued to grow despite standard treatments. About 100 participants will receive the drug through an IV to see if it can shrink tumors and is safe to use. The main goals a…

This study is testing whether two new experimental drugs (HLX87 and HLX22) work better than the current standard treatment when given before surgery for HER2-positive breast cancer. Researchers will enroll 817 adults with early-stage or locally advanced HER2-positive breast cance…

This global study is testing whether new drug combinations work better than standard chemotherapy for advanced squamous lung cancer that has worsened after initial treatment. Researchers will compare two experimental approaches—one using a single new drug and another combining tw…

This study is testing whether a new drug called HLX43, either alone or combined with existing immunotherapies, can help control advanced triple-negative breast cancer. Researchers will enroll 180 adults whose cancer has spread or returned after treatment. The main goals are to se…

This is the first study in people to test a new oral drug called HLX97. It aims to find a safe dose and see early signs of whether it can help control advanced cancers that have spread. The trial will enroll about 138 adults with specific advanced solid tumors, like certain breas…

This study is testing two new drug combinations for people with advanced colorectal cancer that has continued to grow despite standard first-line treatment. It aims to see if these combinations can help control the cancer and are safe for patients. The trial will enroll about 126…

This is the first human study of a new cancer drug called HLX48, designed to test its safety and how it moves through the body. The trial will enroll 72 adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will give increasing doses t…

This study is testing a new two-drug combination for people with advanced lung cancer that has worsened after standard treatments. It aims to find a safe and effective dose and see if the drugs can shrink tumors and control the disease. The trial will enroll about 120 adults who …

This study aims to test a new, under-the-skin injection called HLX15-SC for people newly diagnosed with multiple myeloma who are not eligible for a stem cell transplant. Researchers will compare it to an existing approved treatment (DARZALEX FASPRO®) to see if it works similarly …

This is the first study in people to test a new, experimental drug called HLX3901 for patients with advanced small cell lung cancer or neuroendocrine carcinoma that has worsened after standard treatments. The main goals are to find a safe dose, see how the body processes the drug…